Vanderbilt to Lead $4M PGx Project to Identify HIV Drug Response Markers

Jul 31, 2008

NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases has granted just over $4 million to a Vanderbilt University-led study to identify genetic variations that may predict how individuals will respond to HIV therapies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Main menu